Thomas G. Wiggans, 44 years old, resigned as president and chief operating officer.
Mr. Wiggans had served as president since last March, and as chief operating officer since February 1992.
He will remain a director, the biotechnology company said.
CytoTherapeutics said it has begun a search for a successor.
Mr. Wiggans said he is eager to assume a chief-executive role, and will pursue "discussions with several companies" currently under way.
